Mydecine Innovations Group (TSE:MYCO)

Mydecine Innovations Group (MYCO) Financial Statements


Mydecine Innovations Group Financial Overview

Mydecine Innovations Group's market cap is currently ―. The company's EPS TTM is C$-0.586; its P/E ratio is -0.02; Mydecine Innovations Group is scheduled to report earnings on March 29, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -2.94MC$ -7.42MC$ -5.88MC$ -2.82MC$ -2.38M
EBITDAC$ -2.94MC$ -7.41MC$ -5.87MC$ -2.79MC$ -2.34M
Net Income Common StockholdersC$ -3.18MC$ -7.65MC$ -155.96KC$ -3.32MC$ -2.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 40.46KC$ 565.71KC$ 4.63MC$ 88.93KC$ 324.15K
Total AssetsC$ 1.03MC$ 2.22MC$ 6.90MC$ 3.88MC$ 6.19M
Total DebtC$ 5.25MC$ 5.02MC$ 4.78MC$ 5.11MC$ 4.88M
Net DebtC$ 5.21MC$ 4.45MC$ 153.26KC$ 5.02MC$ 4.56M
Total LiabilitiesC$ 10.11MC$ 10.27MC$ 10.50MC$ 7.94MC$ 8.22M
Stockholders EquityC$ -9.08MC$ -8.05MC$ -3.60MC$ -4.06MC$ -2.03M
Cash Flow-
Free Cash FlowC$ -2.15MC$ -3.00MC$ -1.25MC$ -7.18MC$ -4.05M
Operating Cash FlowC$ -2.15MC$ -3.00MC$ -1.25MC$ -7.18MC$ -4.05M
Investing Cash FlowC$ 25.20KC$ 500.00KC$ -2.08KC$ -35.47KC$ -18.64K
Financing Cash FlowC$ 2.13MC$ 2.50MC$ 1.17MC$ 5.81MC$ 4.14M
Currency in CAD

Mydecine Innovations Group Earnings and Revenue History

Mydecine Innovations Group Debt to Assets

Mydecine Innovations Group Cash Flow

Mydecine Innovations Group Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis